The Challenge
Founded in 2011, OncoSec Medical, Inc. is pioneering gene therapy technology to stimulate the body’s immune system to attack cancer. OncoSec required an innovative Electroporation and Genetic Payload Delivery device capable of accessing cancerous tumors that are beyond the reach of their skin-based technology.
The Solution
Rev.1 developed multiple design solutions capable of accessing tumors deep in the body, stabilize them and deliver OncoSec’s proprietary Genetic Payload within the tumor through electroporation.
The Result
REV·1 delivered a simple, hand-held device that can be introduced in a minimally invasive, outpatient setting to access tumors deep in the body. Currently in pre-clinical trials, this combination product will radically change the treatment of deep-in-the-body, life-threatening tumors.